Polycystic ovary syndrome stories

May 12, 2026

Polycystic Ovary Syndrome Renamed to Polyendocrine Metabolic Ovarian Syndrome After Global Consensus

After more than a decade of discussion, polycystic ovary syndrome (PCOS) has been officially renamed polyendocrine metabolic ovarian syndrome (PMOS) through a global consensus process involving patients and clinicians. The change affects a condition impacting approximately 170 million women worldwide and is expected to improve diagnosis and treatment.

May 12, 2026·8 sources

Polycystic Ovary Syndrome Renamed to Polyendocrine Metabolic Ovarian Syndrome After Decade of Debate

A global consortium of healthcare experts has officially renamed Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS), a change affecting over 170 million women worldwide. Health experts say the new name better reflects the condition's systemic nature and is expected to improve diagnosis and treatment.

May 12, 2026·6 sources

Top claims

▪PMOS is also associated with psychological issues, including anxiety, depression, and eating disorders.
▪Patients reported that under the old name, their non-reproductive symptoms were often dismissed and care was delayed until they sought to conceive.
▪The name PCOS was deemed inaccurate as the condition does not cause an increase in abnormal ovarian cysts.